Jones Hill Capital’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
Jones Hill Capital's IMUX Position: Q3 2026 in Review
Jones Hill Capital sold out of Immunic (IMUX) in Q3 2026, closing a stake of 539,814 shares — an estimated $8.3M sold.
Jones Hill Capital first reported a position in IMUX in Q2 2026 and held it in 1 quarter. The position peaked at $8.3M in Q2 2026. 49 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.
- Jones Hill Capital reported no remaining Immunic position as of Q3 2026 after selling out during the quarter.
- Jones Hill Capital sold 539,814 Immunic shares in Q3 2026, an estimated $8.3M.
- Jones Hill Capital first reported a position in Immunic in Q2 2026 and held it in 1 quarter.
- Jones Hill Capital's Immunic position peaked at $8.3M in Q2 2026.
- 49 funds tracked by Wall St. Rank held Immunic as of Q3 2026.
Based on Jones Hill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.